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Ischemic acute kidney injury (AKI) triggers an inflammatory
response which exacerbates injury that requires increased
expression of endothelial adhesion molecules. To study this
further, we used in situ hybridization, immunohistology, and
isolated endothelial cells, and found increased Toll-like
receptor 4 (TLR4) expression on endothelial cells of the vasa
rectae of the inner stripe of the outer medulla of the kidney
4h after reperfusion. This increase was probably due to
reactive oxygen species, known to be generated early during
ischemic AKI, because the addition of hydrogen peroxide
increased TLR4 expression in MS1 microvascular endothelial
cells in vitro. Endothelial TLR4 may regulate adhesion
molecule (CD54 and CD62E) expression as they were
increased on endothelia of wild-type but not TLR4 knockout
mice in vivo. Further, the addition of high-mobility group
protein B1, a TLR4 ligand released by injured cells, increased
adhesion molecule expression on endothelia isolated from
wild-type but not TLR4 knockout mice. TLR4 was localized to
proximal tubules in the cortex and outer medulla after 24h of
reperfusion. Thus, at least two different cell types express
TLR4, each of which contributes to renal injury by temporally
different mechanisms during ischemic AKI.
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Acute renal ischemia triggers an inflammatory response that
exacerbates injury.1–4 This inflammation requires increased
expression of endothelial adhesion molecules that facilitate
diapedis of leukocytes into renal tissues.5 This requirement
was demonstrated when these molecules were inactivated
by antibodies, transgenic knockout, or antisense, and the
inactivation not only prevented inflammation but also
ameliorated ischemic injury.6–10 Despite their importance
in the inflammatory response to ischemic injury, the
regulation of these endothelial adhesion molecules is not
well understood.
We now suggest that endothelial Toll-like receptor 4
(TLR4) regulates these molecules early after ischemia. We
report that TLR4 appears on the endothelia of the vasa rectae
of the inner stripe of the outer medulla (ISOM) within 4 h of
reperfusion. This increased TLR4 may be important because,
in macrophages, in which the function of TLR4 is best
understood, HMGB1 and other molecules released by injured
and dying cells bind to TLR4 and trigger production of
proinflammatory cytokines.11–15 We suggest that endothelial
TLR4 also triggers inflammation, but through stimulation
of unique endothelial functions—the increased expression
of endothelial adhesion molecules that allow diapedesis of
leukocytes from the blood into injured renal tissues.
Consistent with this suggestion, we find that adhesion
molecules are expressed by wild-type, but not TLR4 (/),
endothelia in vivo. Furthermore, we find that HMGB1
increases adhesion molecule expression on wild-type, but
not TLR4 (/), endothelia in vitro.
Our observations are consistent with and build on
previous reports that TLR4 has a maladaptive role in
ischemic acute kidney injury (AKI). Thus, there was a
beneficial effect of transgenic knockout of TLR4 on ischemic
AKI.16,17 Furthermore, TLR4 was found on radioresis-
tant tubular cells,16,18,19 and stimulation of tubular TLR4
by HMGB1 released by injured renal cells resulted in tubular
apoptosis and cytokine/chemokine production. These
tubular events would contribute significantly to injury
after 24 h.
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However, the effects of TLR4 on ischemic AKI are likely to
be complex and involve more than tubules. Tubules did not
express TLR4 until 24 h and later after reperfusion and may
contribute to injury known to occur after the first 24 h. Our
results suggest that endothelial TLR4 would contri-
bute to early injury by regulating adhesion molecule
expression and thus inflammation. To our knowledge, this
is the first demonstration of renal endothelial TLR4 and its
regulatory role on adhesion molecule expression during
ischemic AKI. Altogether, our data is consistent with the
following hypothesis: during the first 24 h of AKI, acute
ischemic injury results in the release of HMGB1; HMGB1
interacts with endothelial TLR4; this activates endothelial
cells to express adhesion molecules; these endothelial
adhesion molecules allow the maladaptive inflammation that
exacerbates ischemic AKI.
The contribution of TLR4 to ischemic AKI is complex.
At least two different cell types—renal tubules, as previously
reported,16,18,19 and renal endothelia, as we now report—
express TLR4. Each cell type contributes to renal injury by
means of different mechanisms and at a different time after
reperfusion.
RESULTS
At 4h reperfusion, increased endothelial TLR4 on the vasa
rectae of the ISOM
After 23min of clamping, but no reperfusion, TLR4 mRNA
already increased by 1.8-fold compared with sham (Figure 1).
TLR4 expression further increased to a maximum at 4 h
reperfusion, gradually decreased over the next 18 h reperfu-
sion, but was still elevated at 24 h.
Because TLR4 had not previously been found in the
ischemic kidney before 24 h reperfusion, we used four
independent techniques to confirm and localize the increased
expression of TLR4 at 4 h reperfusion: dissection of the
various sections of the kidney, in situ hybridization,
immunohistology, and analysis of freshly isolated endothelial
cells. All four techniques, discussed below, are consistent with
increased TLR4 on endothelia of the vasa rectae of the ISOM
during ischemic AKI.
(1) Localization of increased TLR4 to the ISOM by
dissection. Gross changes in the kidney after ischemia and 4 h
of reperfusion allow its dissection into three separate
compartments;20–22 there is congestion of red cells in the
ISOM that allows its easy identification and dissection as a
single compartment (Figure 2a). The (cortexþOSOM (outer
stripe of the outer medulla)) is identified as the pale structure
outside the ISOM, and the inner medulla is identified by its
characteristic papillary shape. We compared TLR4 mRNA in
each of these compartments in Figure 2b and 2c; most of the
TLR4 is localized to the ISOM.
To compare TLR4 expression in ischemic and sham
kidneys, a modified dissection strategy was used because, in
contrast to ischemic kidneys, there is little vascular conges-
tion in the ISOM of sham kidneys, and the ISOM cannot be
readily differentiated from the (OSOMþ cortex). Therefore,
these three regions must be dissected as a single compart-
ment, that is, the (ISOMþOSOMþ cortex); the remaining
compartment is the inner medulla. Figure 2b shows that
TLR4 mRNA in the inner medulla did not change after
ischemia. In contrast, ischemia/reperfusion increased TLR4
mRNA in the (ISOMþOSOMþ cortex) by 2.5-fold. As
discussed in the previous paragraph, most of this increase is
in the ISOM (Figure 2c).
(2) Localization of TLR4 mRNA in the ISOM to the
ischemic vasa rectae by in situ hybridization. Although at 4 h,
TLR4 was found on both the inner medulla and the ISOM,
we focus the remainder of this study on events in the ISOM,
because this is the region of greatest injury and inflammation
during ischemic AKI (see reviews by Lieberthal et al.,23
Thadhani et al.,24 Brezis and Rosen25). Thus, understanding
TLR4 expression at this site may result in understanding the
mechanisms at the major site of structural injury during
ischemic AKI.
By in situ hybridization, we found TLR4 mRNA in the
ISOM of ischemic kidneys at 4 h reperfusion (Figure 3a), but
not in sham kidneys (Figure 3c). Control radiolabeled sense
TLR4 RNA did not reveal staining of the ischemic kidney
(Figure 3b). The area of the red box in Figure 3a was studied
in greater detail in Figure 3d–f. These panels suggest that
the TLR4 mRNA was localized to endothelial cells of the
vasa rectae. In serial sections, the same structures (denoted by
white arrows) were positive by staining with antibodies
to von Willebrand’s factor (Figure 3e) and TLR4 mRNA
(Figure 3f), and had the morphology of endothelial cells on
brightfield examination of hematoxylin-and-eosin-counter-
stained slides (Figure 3d). This technique measures silver
grains precipitated by radiation emitted from the S35
antisense probe bound to TLR4 mRNA. These grains may
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Figure 1 | Toll-like receptor 4 (TLR4) mRNA abundance in
ischemic kidney peaks at 4 h reperfusion. The mean values and
standard deviation errors of four kidneys per point are shown. The
y axis is the TLR4/GAPDH mRNA determined by quantitative
reverse transcription-PCR and analyzed by the comparative
Ct method. At each time point, the TLR4 Ct is normalized to the
GAPDH Ct. The calibrator gene is TLR4 for the sham kidney at time
zero, when the renal arterial clamp was removed. Po0.05
between sham and AKI at each time point.
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be some distance from the source. Therefore, our conclusion
that endothelia express TLR4 rests not only on in situ
hybridization alone but also on immunohistology and on the
study of isolated endothelial cells discussed below.
(3) Localization of TLR4 proteins in the ISOM to the
ischemic vasa rectae by immunohistology. We use three
different protocols and two different anti-TLR4 antibodies to
demonstrate endothelial TLR4. In Figure 4, we use double
immunostaining with a phycoerythrin-conjugated monoclo-
nal anti-TLR4 and von Willebrand’s factor at 4 h reperfusion
to also show that vasa rectae are positive for TLR4. In
Figure 5, we use a rat monoclonal anti-TLR4, a biotinylated
goat antirat secondary antibody, and Texas red streptavidin to
localize TLR4 on endothelium. Semiserial sections suggest
that TLR4 (Figure 5a) is located on the same interstitial
structures as CD31 (Figure 5b), which is an endothelial
marker. In Supplementary Figure S5 online, we use a
polyclonal anti-TLR4, and an alkaline-phosphatase-labeled
secondary antibody. This figure shows staining of interstitial
structures that are likely endothelium (Supplementary Figure
S5A online), and also shows the absence of nonspecific
staining (Supplementary Figure S5B online).
All together, the experiments in this section use three
different techniques—gross dissection, in situ hybridization,
and also immunostaining with three different protocols with
two different anti-TLR4 antibodies. Data using all three
techniques are consistent with the presence of TLR4 on
endothelia in the ISOM of ischemic kidneys at 4 h reperfu-
sion. In addition, later in this paper, we discuss a fourth
technique, analysis of isolated endothelial cells from ischemic
versus sham kidneys. This also confirmed the increased TLR4
expression on ischemic renal endothelia (Figure 8).
Reactive oxygen species stimulate endothelial TLR4
expression
The above studies show that renal endothelial TLR4 increases at
4 h reperfusion in vivo. To determine whether this increase was
a direct result of endothelial stress occurring during ischemia/
reperfusion, we used an in vitro model of ischemic AKI, stress
by H2O2.
26 H2O2 and other reactive oxygen species are
produced during both ischemia and reperfusion27–29 and
should stress endothelia in vivo. We exposed MS1 micro-
vascular endothelial cells to H2O2 for 30min. The cells were
then allowed to recover in complete medium containing FCS
and no H2O2. This treatment stimulated TLR4 expression
(Figure 6a). The kinetics of TLR4 expression were similar to
that in vivo and previously shown in Figure 1. Thus, maximum
TLR4 expression occurred after cells had recovered from H2O2
for 4 h, and diminished by 24 h.
Another in vitro model of ischemic AKI is stress by
tunicamycin.30 This agent inhibits glycosylation of proteins
and thus prevents appropriate protein folding in the
endoplasmic reticulum. This triggers endoplasmic reticulum
stress and an ‘unfolded protein response’ that ultimately
regulates gene transcription and other cell functions. Similar
endoplasmic reticulum stress occurs during AKI because
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Figure 2 | Toll-like receptor 4 (TLR4) expression in regions of the
kidney. (a) Ischemic kidney. The kidney has been dissected along its
long axis and the dark lines show how the (OSOMþ cortex) may be
dissected from the congested (red) inner stripe of the outer medulla
(ISOM), and the ISOM from the inner medulla (papilla) as described in
the text. The inset shows a kidney cut along its short axis and the
dotted lines show how the (OSOMþ cortex) was dissected from the
ISOM from this view. (b) Ischemia increases TLR4 mRNA in the
(ISOMþOSOMþ cortex) but not in the inner medulla. The x axis is
the TLR4 mRNA determined by quantitative reverse transcription
(qRT)-PCR with the Ct normalized to GAPDH Ct. This value is further
adjusted to take into account the fact that the inner medulla
comprised 3±1% (n¼ 3, mean±s.e.) of the total mass of the kidney.
We assumed uniform distribution of GAPDH throughout the kidney;
therefore, the values displayed on the x axis for the inner medulla are
3dCT (TLR4/GAPDH), and that for the ISOMþOSOMþ cortex is
97dCT (TLR4/GAPDH). (c) Greater TLR4 expression in the ischemic
ISOM compared with the (OSOMþ cortex). The x axis is the TLR4
mRNA determined by qRT-PCR and the comparative Ct method.
TLR4 Ct is normalized to the GAPDH Ct. The calibrator gene is TLR4 in
the ischemic OSOMþ cortex. Each value shown in b and c is the
mean±s.e. of six determinations. Po0.05 between sham and
ischemic kidneys in b, and between ISOM and (OSOMþ cortex)
in c. OSOM, outer stripe of the outer medulla.
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ischemia disrupts the adenosine triphosphate concentrations
and the cellular oxidative state required for appropriate
protein folding.31–34 We found that endoplasmic reticulum
stress (tunicamycin) also stimulates MS1 microvascular
endothelial cells to express TLR4 (Figure 6b).
Endothelial activation during ischemic AKI requires TLR4
If endothelial TLR4 is important in the pathophysiology of
ischemic AKI, then expression of critical endothelial adhesion
molecules should depend on a functional TLR4 gene.
We took two approaches to address this question. First, we
determined the effect of a TLR4 deletion mutation on these
endothelial adhesion molecules during ischemic AKI in vivo.
Second, we determined the effect of this TLR4 deletion
mutation on the ability of HMGB1 to stimulate endothelial
adhesion molecule expression in vitro. HMGB1 is a damaged
associated molecule11–14 released by injured cells during
ischemic AKI.16
Effect of a TLR4 deletion mutation on endothelial adhesion
molecules during ischemic AKI in vivo. We compared the effect
of TLR4 genotype on endothelial genes required for the
inflammatory response to ischemic AKI; these include
endothelial adhesion molecules such as E-selectin (CD62E)
and ICAM1 (CD54).5–10,35 For this comparison, we devel-
oped a quantitative assay to assess the role of TLR4 in
regulating these genes. We used anti-CD31-conjugated
Dynabeads (Invitrogen, Carlsbad, CA) to retrieve endothelial
cells from enzymatically dispersed kidneys. Before using this
technique in the ischemic AKI system, we validated it.
Figure 7 shows that this technique did indeed isolate
endothelial cells. The CD31-positive cells from both sham
(Figure 7a) and AKI (Figure 7b) kidneys expressed
endothelial markers CD31, CD54, and CD106. In addition
to these commonly used markers for endothelia, we also used
ESM1 (endothelial-specific molecule 1, or endocan), which is
only expressed by endothelia.36 Cells not binding to the anti-
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Figure 3 |Toll-like receptor 4 (TLR4) mRNA localized to inner stripe of the outer medulla (ISOM) by in situ hybridization. Wild-type
kidneys were studied at 4 h reperfusion. (a) Ischemic antisense. The darkfield photomicrograph shows in situ hybridization for TLR4 mRNA in
ischemic kidney using antisense S35 TLR4 mRNA. White dots denote aggregates of silver grains overlying TLR4 mRNA. Red arrows denote
increased expression of TLR4 in the vascular bundles of the ISOM of the ischemic kidney. One of these vascular bundles is outlined by a red
box that is further studied in d–f. (b) Ischemic sense. This negative control shows the absence of staining of the ischemic kidney hybridized
with sense S35 TLR4 mRNA. (c) Sham antisense. This negative control shows the absence of TLR4 mRNA in the non-ischemic kidney.
(d) Bright field hematoxylin and eosin. Serial sections of the area delineated by the red box in a were studied. Arrows point to the same vasa
rectae in the serial sections d–f. (e) Immunostaining with anti-vWF (von Willebrand’s factor), which stains the endothelium. (f) In situ
hybridization for TLR4. White dots indicate in situ hybridization with S35-labeled antisense TLR4 RNA.
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CD31 beads expressed much lower, often undetectable, levels
of these endothelial markers. Therefore, the anti-CD31 beads
may be used to isolate and study CD31 endothelial cells from
both sham and AKI kidneys. Note that this experiment was
designed to compare CD31-positive versus CD31-negative
cells in either sham or AKI kidneys. It was not designed to
compare CD31 cells in sham versus AKI kidneys.
Using this technique, we confirmed the increased expression
of endothelial TLR4 at 4 h reperfusion in wild-type kidneys.
TLR4 expression on isolated CD31-positive cells is increased by
2.28±0.13-fold in AKI compared with sham kidneys (Figure 8).
This increased TLR4 on endothelial cells confirms our in situ
hybridization (Figure 3) and immunohistochemistry results
(Figures 4, 5, and Supplementary Figure S5 online).
We noted a very small increase in TLR4 in the whole sham
kidney at 4 h (Figure 1), and suspected that this increase was
a response to cytokine release from muscle and skin injured
during the sham surgery, which included laparotomy, right
nephrectomy, and dissection to expose the left renal artery. This
small amount of TLR4 mRNAwas below the limit of detection
in the sham kidney by in situ hybridization (Figure 3), and we
detected no statistically significant increase or decrease in TLR4
on endothelial cells isolated from sham kidneys (Figure 8). The
source of the small increase in TLR4 mRNA in the sham kidney
of Figure 1 is not known.
In addition, Figure 8 shows that endothelial TLR4 had
decreased toward baseline levels at 24 h reperfusion. This is in
contrast to the sustained high levels of TLR4 mRNA seen at
24 h reperfusion in the whole kidney (Figure 1). These results
are explained by the appearance of TLR4 on tubules (Figure 9).
We identified these as proximal tubules by colocalization with
Lotus tectragonolobus lectin37,38 in the cortex and OSOM
(Figure 10). Thus, the total amount of TLR4 remains elevated
for at least 24 h after reperfusion, but TLR4 is expressed on
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Figure 4 | Immunofluorescence shows colocalization of Toll-like receptor 4 (TLR4) and von Willebrand’s factor on the vasa rectae of
the ischemic inner stripe of the outer medulla (ISOM). The ischemic kidney was studied at 4 h reperfusion. The same tissue section is
shown in all panels, but different input and output light filters were used. Blue is 4,6-diamidino-2-phenylindole. (a) TLR4 visualized with
phycoerythrin-conjugated monoclonal rat anti-mouse TLR4 (Santa Cruz, sc 13591). (b) Endothelia visualized with anti-von Willebrand’s
antibody and then goat anti-rabbit IgG-Cy3. (c) Overlap of a and b.
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different cells at different times. At 4 h, TLR4 is expressed on
endothelial cells; at 24 h, expression is on tubular cells.
If TLR4 is required for the expression of endothelial
activation markers, then these markers should appear on
endothelial cells during AKI of wild-type, but not TLR4
(/), kidneys. Figure 11 confirms this prediction for CD54,
CD106, and CD62E at 4 h reperfusion.
Effect of a TLR4 deletion mutation on the ability of HMGB1 to
stimulate endothelial adhesion molecule expression in vitro. The
above data show a critical role for TLR4 in endothelial
activation in vivo, but does not show whether this role is
directly mediated by TLR4 on endothelia or indirectly through
cytokines released by other cells. To address this question, we
tested the ability of wild-type versus TLR4 (/) endothelia
to be stimulated by HMGB1 in vitro. This molecule is a
‘damage-associated-molecular pattern molecule’3,15,39 that is
released by damaged cells during ischemic AKI16 and that is a
ligand for TLR4. We found that HMGB1 increased endothelial
adhesion molecules (CD54, CD106, and CD62E) in wild-type
renal endothelia, isolated using anti-CD31 Dynabeads
(Figure 12a). In contrast, renal endothelia isolated from TLR4
(/) mice did not respond to HMGB1 in vitro (Figure 12b).
Note that HMGB1 increases CD62E expression in wild-type
endothelia, but lipopolysaccharide does not. This illustrates the
known difference in signaling by different TLR4 ligands; each
ligand may activate its own TLR4 receptor complex and
intracellular signaling pathways.40 Another relevant example is
the TLR4-dependent abilities of lipopolysaccharide to decrease,
but HMGB1 to increase, the carcinogenicity of croton oil.41
All together, our in vivo and in vitro data suggest that
direct stimulation of TLR4 on endothelial cell surfaces results
in expression of endothelial adhesion molecules that are
important for the inflammatory response to AKI.
DISCUSSION
Acute renal ischemia elicits an inflammatory response that
exacerbates injury; this inflammation requires the increased
expression of endothelial adhesion molecules that facilitate
diapedesis of leukocytes into renal tissues. 1–10 However, the
regulation of these endothelial adhesion molecules is not well
understood.
On the basis of observations made in this study, we now
suggest that endothelial TLR4 contributes to this regulation.
First, we show increased expression of endothelial TLR4 of the
ISOM at 4h reperfusion. Because TLR4 had previously been
reported only on tubules at 24h and later, we used four different
techniques to confirm our new findings: analysis of dissected
renal tissues, in situ hybridization, immunohistology, and
analysis of isolated renal endothelial cells. Second, we developed
a technique for isolating renal endothelia and quantitatively
assaying their expression of adhesion molecules. We find
increased expression of adhesion molecules during ischemic
AKI only in wild-type, but not TLR4 (/), endothelia. Third,
we find that HMGB1, released by injured renal cells during
ischemic AKI, interacts with endothelial TLR4 to activate
adhesion molecule expression only by wild-type, but not TLR4
(/), endothelia in vitro. Finally, transgenic knockout of TLR4
ameliorates ischemic injury and inflammation;16,17 this shows a
role for TLR4 in ischemic AKI. We propose that one role is the
regulation of endothelial adhesion molecule expression. All
together, these observations are consistent with the idea that
endothelial TLR4 regulates the expression of the endothelial
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Figure 5 | Localization of Toll-like receptor 4 (TLR4) and the endothelial marker CD31 in the ischemic outer medulla. (a) TLR4 staining
(bright red). Arrowhead shows one of many TLR4-positive peritubular endothelia. Arrow shows a nucleus (4,6-diamidino-2-phenylindole
positive) that has the elongated shape typical of endothelial nuclei and that is surrounded by staining for TLR4. (b) CD31 staining. Semiserial
section to a. Arrowhead shows one of many CD31-positive endothelia. Arrows show two endothelial nuclei (blue) surrounded by CD31
staining (bright green). ‘T’ shows several of many tubules in a and b. Anti-TLR4 appears to stain CD31-positive endothelia.
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adhesion molecules required for the inflammatory response to
injury early after ischemia/reperfusion.
Although our proposed role for endothelial TLR4 has not
previously been demonstrated in ischemic AKI, such a role
has been shown during ischemic injury of the cremaster
muscle,42 and during endotoxin injury of the lung.43
Further support for our hypothesis is the localization of
TLR4 to endothelia of the ISOM. The medullary thick
ascending limb and the S3 straight proximal tubule that
reside in this area are the tubules most vulnerable to ischemic
injury in both rodents and humans.23,44–48 During ischemic
AKI, injury to these cells should result in the release of
HMGB1, and this HMGB1 should stimulate TLR4 on the
adjacent endothelium. Because of endothelial activation in
the ISOM, this is the area of greatest inflammation during
ischemic AKI.5
At 24 h, but not 4 h, reperfusion, we found TLR4 protein
on proximal tubules. To our knowledge, these are the first
studies to use double immunofluorescence for TLR4 and
tubule-specific markers to localize TLR4. At even later
reperfusion times (days 3–5), TLR4 has also been reported
on distal tubules and medullary thick ascending limb cells by
using anti-Tamm Horsfall antibodies and in situ hybridiza-
tion for TLR418 and on proximal tubules and distal nephrons
by using anti-TLR4 antibodies; tubules were identified by
morphology alone.19 Although we see strong, consistent
expression of TLR4 on proximal tubules, we did occasionally
see inconsistent staining of more distal segments. This study
is focused on endothelial expression of TLR4 and events
during the first 4 h of reperfusion; ongoing studies in our
laboratory pursue the localization and functions of TLR4 on
tubules and other cells after 24 h of reperfusion.
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Figure 7 |Validation of anti-CD31 Dynabeads as an isolation
method for renal endothelial cells. (a) Endothelial markers
on isolated CD31þ cells from sham wild-type kidneys.
(b) Endothelial markers on isolated CD31þ cells from acute kidney
injury (AKI) wild-type kidneys. The y axis is the gene of interest/
GAPDH mRNA measured by quantitative reverse transcription-
PCR and analyzed by the comparative Ct method. The calibrator
gene is the gene of interest in the anti-CD31 Dynabead-purified
population. ‘CD31þ ’ cells are those binding to anti-CD31 beads.
‘Non-CD31þ ’ cells are those not binding to anti-CD31 beads.
Po0.05 for each pairwise comparison between CD31þ and
non-CD31þ for each endothelial cell marker.
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Figure 6 | Endothelial Toll-like receptor 4 (TLR4) is directly
increased by stress in vitro. Confluent MS1 murine endothelial
cells were treated with H2O2 (a) or tunicamycin in Earl’s Balanced
Solution (EBSS) (b) for 30min, and assayed for TLR4 mRNA
immediately (zero time) or recultured in complete medium
without H2O2 or tunicamycin and assayed after 4 or 24 h. The y
axis is the TLR4/GAPDH mRNA determined by quantitative reverse
transcription-PCR and analyzed by the comparative Ct method
(see Materials and Methods section). The calibrator gene is TLR4
expression in the untreated control in EBSS for 30 min and in
complete medium at the given recovery time. Means and
standard errors are shown; *Po0.05.
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Although tubular TLR4 would regulate injury after 24 h, it
would not affect earlier injury and inflammation. We suggest
that this earlier injury results from TLR4 expression on renal
endothelia, on the TLR4-dependent expression of endothelial
adhesion molecules and on the ensuing inflammation. The
different timing of TLR4 expression by tubules and
endothelia reflects the different regulation of this molecule
on these two cell types. During ischemic AKI, reactive oxygen
species is released early during ischemia/reperfusion.26–28 We
found that this reactive oxygen species increased endothelial
TLR4 expression in vitro. This is consistent with the early
expression of TRL4 on endothelia. On the other hand,
tubular TLR4 is stimulated by interferon-g and tumor
necrosis factora.18 This is consistent with the late expression
of these cytokines.49–51
All together, our observations support the maladaptive
role of endothelial activation in ischemic AKI,5,6,35,52–55 and
also support the following hypothesis: at 4 h reperfusion,
acute ischemic injury results in the release of HMGB1;
HMGB1 interacts with endothelial TLR4; this activates
endothelial cells to express adhesion molecules; these
endothelial adhesion molecules allow the maladaptive
inflammation that exacerbates ischemic AKI.
In conclusion, the contribution of TLR4 to ischemic AKI
is complex, and just beginning to be understood. At least two
different cell types—renal tubules, as previously re-
ported,16,18,19 and renal endothelia, as now reported—
express TLR4. Each cell type contributes to renal injury in
a different way and at a different time after reperfusion.
MATERIALS AND METHODS
Animal model
Male C57BL/6J or C57BL/10J, 6–8 weeks of age, were from the
Jackson Laboratory (Bar Harbor, ME). These differ with respect to
only three genes (see Jackson Laboratory, Website: http://www.in-
formatics.jax.org/external/festing/mouse/docs/C57BL.shtml.); we
found no difference in their response to ischemia. TLR4 (/)
mice were C57BL/10ScN/J mice (Jackson Laboratory), which were
always compared with congenic (TLR4-þ /þ ) C57BL/10J. Mice
were anesthetized using isoflurane at 371C by a TR-200 system with
a rectal probe (Fine Science Tools, Foster City, CA). After a right
nephrectomy, the left pedicle was occluded with a microaneurysm
clip (Codman, Rayham, MA) for 23min. Sham mice underwent the
same procedure, except that the clip was put underneath the pedicle.
The protocol was approved by our Institutional Animal Care and
Use Committee.
In situ hybridization
The TLR4 fragment was amplified using published primers,18,56
subcloned into pDrive cloning Vector (Qiagen, Valencia, CA). S35
labeled sense probes were prepared after linearization of the plasmid
with BamHI and transcribed with SP6 polymerase; antisense probes
were prepared after linearization with NotI and transcription with
T7 polymerase. Hybridization was performed on paraffin-embedded
sections.
Immunohistology
In Figure 4, kidneys were fixed in Immunohistofix, embedded in
Immunohistowax (Intertiles, Brussels, Belgium),57 sections stained
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Figure 8 | Toll-like receptor 4 (TLR4) mRNA expression on
CD31þ cells of wild-type sham versus acute kidney injury
(AKI) kidneys. TLR4 mRNA on CD31þ cells was measured by
quantitative reverse transcription-PCR and analyzed by the
comparative Ct method. The calibrator gene is the sham kidney at
0 h reperfusion. Po0.05 between sham and AKI kidneys at each
time point.
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Figure 9 | Immunohistochemistry of Toll-like receptor 4 (TLR4) at 24 h reperfusion shows tubular, not endothelial, TLR4 expression
in wild-type kidneys. (a) Sham wild-type kidneys; TLR4 at 24 h reperfusion. (b) Acute kidney injury (AKI) wild-type kidneys; TLR4 at 24 h
reperfusion. ‘t’ shows several tubules that express TLR4 at 24 h reperfusion. 4,6-Diamidino-2-phenylindole (blue) and anti-TLR4 (red).
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with phycoerythrin-conjugated monoclonal rat anti-mouse TLR4
(Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-mouse von
Willebrand’s factor antibody (Abcam, Cambridge, MA), and then
goat anti-rabbit IgG-Cy3(Jackson ImmunoResearch Laboratories,
West Grove, PA). In Supplementary Figure 5 online, renal tissue was
fixed by 10% formalin, embedded in paraffin, and immunostained
with primary rabbit anti-mouse polyclonal TLR4 (SC-10741, Santa
Cruz Biotechnology) and secondary biotinylated goat anti-rabbit
antibody. Endogenous alkaline phosphatase was inactivated with
levamisole, and endogenous biotin was blocked by the streptavi-
din–biotin block system. Sections were stained with Fast Red (Vector
Laboratories, Burlingame, CA). Normal rabbit immunoglobulin G
(IgG) was used as control. In Figures 5, 9, and 10, the left kidney was
in situ perfused with cold phosphate-buffered saline, followed by
cold 4% paraformaldehyde, fixed in 4% paraformaldehyde at 41C
for 1 h, transferred into 20% sucrose, embedded with OCT (Tissue-
Tek, Sacura, Torrance, CA), snap-frozen in isopentane, fixed in 4%
paraformaldehyde, and blocked with 10% normal goat serum.
Sections were incubated with rat anti-mouse TLR4 (R&D Systems,
a  Anti-TLR4
b  Isotype T
c   Anti-TLR4
d   Anti-TLR and LTA Merge
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Figure 10 |Proximal tubular Toll-like receptor 4 (TLR4) at 24 h
reperfusion. (a) Outer stripe of the outer medulla (OSOM) stained
for TLR4 (red). (b) OSOM stained with isotype control primary
antibody. Exposure times for a and b are identical. (c) High-power
view of OSOM stained for TLR4. ‘T’ is one of many tubules in c–e.
(d) Merged lotus tetragonolobus lectin (LTA) and TLR4 of same
section. Blue is 4,6-diamidino-2-phenylindole (DAPI) staining of
nuclei. DAPI staining reveals nuclei. LTA marks proximal tubule
cells. (e) High-power view of same section stained for LTA.
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Figure 11 | Endothelial markers on CD31þ cells from sham
versus acute kidney injury (AKI) kidneys of wild-type versus
Toll-like receptor 4 (TLR4) (/) mice. Kidneys clamped for
23min and then studied at 4 and 24 h reperfusion. Endothelial
cells isolated by anti-CD31 Dynabeads. The y axis is the gene of
interest/GAPDH mRNA measured by quantitative reverse
transcription-PCR and analyzed by the comparative Ct method.
The calibrator gene is the gene of interest in sham kidneys.
(a) Wild-type kidneys at 4 h reperfusion. (b) TLR4 (/) kidneys at
4 h reperfusion. Po0.05 for pairwise comparisons between sham
and AKI kidneys for each marker in a.
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Minneapolis, MN) for 2 h, followed by biotinylated goat anti-rat IgG
(Santa Cruz Biotechnology) for 30min, then Texas red-streptavidin
(Vector Laboratories) for 30min. Rat IgG2a was the control. For
double staining, fluorescein-lotus tetragonolobus lectin (Vector
Laboratories) was applied for 20min. Sections were moun-
ted with VECTASHIELD Mounting Medium with 4,6-diamidino-
2-phenylindole (Vector Laboratories) and visualized using a Carl
Zeiss Axioplan2 Imaging microscope (Carl Zeiss MicroImaging,
Thornwood, NY).
Endothelial cells in vitro
The murine pancreatic endothelial cell line MS1 was purchased from
ATCC (Manassas, VA). Cells were cultured in complete media—
Dulbecco’s Modified Eagle Medium (Invitrogen, Carlsbad, CA)
supplemented with 10% fetal calf serum (Hyclone, Logan, Utah),
2mM L-glutamine, 100U/ml penicillin, and 100 mg/ml streptomycin
(Invitrogen), and incubated in a humidified atmosphere at 371C
(5% CO2). Confluent MS1 monolayers were washed with Dulbecco’s
phosphate-buffered saline three times. Cells were then treated with
H2O2 (500mM, Sigma, St Louis, MO) or tunicamycin (4 mg/ml,
Sigma) for 30min in Earle’s Balanced Salt Solution at 371C. After
stress exposure, cells were replenished with complete medium
containing 10% fetal calf serum and incubated for an additional 4 or
24 h at 371C.
Endothelial cell isolation
Kidney tissues were minced into 1–2mm fragments and dissociated
in phosphate-buffered saline with Liberase Blendzyme 3 (Roche,
Indianapolis, IN) (0.18 Wunsch Units/ml) at 371C for 25min with
gentle shaking. Dynabeads Sheep anti-rat IgG (Invitrogen) (25 ml)
was coated with 1.5 mg of rat anti-mouse CD31 (MEC13.3, BD
Pharmingen, San Jose, CA). Tissue digest was filtered through 40 mm
cell strainer, incubated with Dynabeads at 41C for 20min, and
washed.
HMGB1 treatment of primary renal endothelial cells
Endothelial cells isolated from wild-type B10 or TLR4-null kidneys
were resuspended in complete medium and incubated at 371C (5%
CO2). Cells were treated with recombinant human HMGB1 (R&D
Systems) at 5mg/ml or 10 mg/ml for 2 h or with an ultrapure form of
lipopolysaccharide that activates only TLR4 (Escherichia coli
0111:B4, InvivoGen, San Diego, CA).
RNA isolation and real-time reverse transcription-PCR
Kidney tissues were snap-frozen in liquid nitrogen, stored at 801C,
disrupted using PowerGen 700 homogenizer (Fisher Scientific,
Pittsburgh, PA), and total RNA extracted by an RNeasy Midi kit
(Qiagen). Total RNA from endothelial cells was extracted with an
RNeasy Mini kit (Qiagen). RNA was treated with a Turbo DNA-free
kit (Applied Biosystems, ABI, Carlsbad, CA). 1 mg of total RNA was
reverse transcribed using a High Capacity cDNA reverse transcrip-
tion kit (ABI). Confirmation by melting point analysis and relative
quantitation of each gene were performed using SYBR Green PCR
Reagents and an ABI PRISM 7000 Sequence Detection System. The
comparative Ct (cycle threshold) of each gene of interest was
normalized to the GAPDH Ct determined under the same
conditions.58 The following are the PCR primers: GAPDH forward
50-AGGTCGGTGTGAACGGATTTG-30, reverse 50-TGTAGACCATG
TAGTTGAGGTCA-30; TLR4 forward 50-AAACGGCAACTTGGACC
TGA-30, reverse 50-AGCTTAGCAGCCATGTGTTCCA-30; ESM1
forward 50-ATTGCCAGTCGGGCATATGTGA-30, reverse 50-TTCTC
TCACAGCGTTGCCAT-30; CD31 forward 50-AGGAAAGCCAAGGC
CAAACA-30, reverse 50-AATGGCTGTTGGCTTCCACACT-30;
ICAM1 (CD54) forward 50-AGCCAATTTCTCATGCCGCACA-30,
reverse 50-AGCTTTGGGATGGTAGCTGGAA-30; VCAM1 (CD106)
forward 50-TTCGGTTGTTCTGACGTGTGCT-30, reverse 50-AGAGC
TCAACACAAGCGTGGAT-30; E-selectin (CD62E) forward 50-AGC
CTGCCATGTGGTTGAATGT-30, reverse 50-AACGTGCATGTCGTG
TTCCA-30.
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Figure 12 |HMGB1 activates wild-type, but not Toll-like
receptor 4 (TLR4) (/), endothelial cells in vitro. Endothelial
cells were isolated from unmanipulated wild-type (a) or TLR4/
(b) kidneys using anti-CD31 Dynabeads. These cells were
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Figure S5. Immunoalkaline phosphatase shows TLR4 on endothelia
of the ischemic outer medulla.
Supplementary material is linked to the online version of the paper at
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